Canada NewsWire
TORONTO, April 26, 2016
TORONTO, April 26, 2016 /CNW/ - Dan Chicoine, Chairman & CEO, Crescita Therapeutics Inc. (CTX), joined Rob Peterman, Director, Global Business Development, Toronto Stock Exchange & TSX Venture Exchange, to open the market. Crescita Therapeutics is a biotech company that owns a pipeline of topical and transdermal product candidates for treating medical conditions in a number of therapeutic areas, including pain and dermatology. Crescita was created on March 1, 2016 by the reorganization of Nuvo Research Inc. into two separate publicly traded companies. Crescita Therapeutics Inc. commenced trading on Toronto Stock Exchange on March 7, 2016. For more information, please visit www.crescitatherapeutics.com.
SOURCE TMX Group Limited
Image with caption: "Dan Chicoine, Chairman & CEO, Crescita Therapeutics Inc. (CTX), joined Rob Peterman, Director, Global Business Development, Toronto Stock Exchange & TSX Venture Exchange, to open the market. Crescita Therapeutics is a biotech company that owns a pipeline of topical and transdermal product candidates for treating medical conditions in a number of therapeutic areas, including pain and dermatology. Crescita was created on March 1, 2016 by the reorganization of Nuvo Research Inc. into two separate publicly traded companies. Crescita Therapeutics Inc. commenced trading on Toronto Stock Exchange on March 7, 2016. For more information, please visit www.crescitatherapeutics.com. (CNW Group/TMX Group Limited)". Image available at: http://photos.newswire.ca/images/download/20160426_C4536_PHOTO_EN_675156.jpg
www.crescitatherapeutics.comCopyright CNW Group 2016